Franklin Resources’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.15M | Buy |
176,949
+3,990
| +2% | +$71K | ﹤0.01% | 1540 |
|
2025
Q1 | $3.08M | Buy |
172,959
+16,895
| +11% | +$301K | ﹤0.01% | 1533 |
|
2024
Q4 | $4.65M | Sell |
156,064
-24,789
| -14% | -$739K | ﹤0.01% | 1374 |
|
2024
Q3 | $2.9M | Buy |
180,853
+124,793
| +223% | +$2M | ﹤0.01% | 1590 |
|
2024
Q2 | $960K | Sell |
56,060
-455
| -0.8% | -$7.79K | ﹤0.01% | 1938 |
|
2024
Q1 | $883K | Buy |
56,515
+2,220
| +4% | +$34.7K | ﹤0.01% | 2001 |
|
2023
Q4 | $811K | Buy |
+54,295
| New | +$811K | ﹤0.01% | 1723 |
|
2023
Q3 | – | Sell |
-6,902
| Closed | -$286K | – | 2737 |
|
2023
Q2 | $286K | Buy |
6,902
+1,083
| +19% | +$44.9K | ﹤0.01% | 2218 |
|
2023
Q1 | $350K | Sell |
5,819
-1,390
| -19% | -$83.6K | ﹤0.01% | 1810 |
|
2022
Q4 | $529K | Buy |
7,209
+909
| +14% | +$66.7K | ﹤0.01% | 1681 |
|
2022
Q3 | $478K | Buy |
6,300
+1,135
| +22% | +$86.1K | ﹤0.01% | 1692 |
|
2022
Q2 | $360K | Buy |
5,165
+312
| +6% | +$21.7K | ﹤0.01% | 1812 |
|
2022
Q1 | $402K | Buy |
4,853
+851
| +21% | +$70.5K | ﹤0.01% | 1908 |
|
2021
Q4 | $301K | Sell |
4,002
-551
| -12% | -$41.4K | ﹤0.01% | 2077 |
|
2021
Q3 | $528K | Sell |
4,553
-718
| -14% | -$83.3K | ﹤0.01% | 1860 |
|
2021
Q2 | $1.17M | Sell |
5,271
-3,842
| -42% | -$853K | ﹤0.01% | 1450 |
|
2021
Q1 | $1.21M | Sell |
9,113
-94,496
| -91% | -$12.5M | ﹤0.01% | 1437 |
|
2020
Q4 | $17.9M | Buy |
103,609
+101,504
| +4,822% | +$17.6M | 0.01% | 831 |
|
2020
Q3 | $234K | Buy |
+2,105
| New | +$234K | ﹤0.01% | 1619 |
|